Expression of POU-Domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression

7Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The POU-domain transcription factor Oct-6 has been reported to be differentially expressed between schizophrenic and control post-mortem brains. In this study, we attempted to replicate this finding and to discover whether Oct-6 was also dysregulated in bipolar disorder and major depression. Methods: Oct-6 mRNA and protein expression were determined by in-situ hybridization and immunohistochemistry respectively in sections of post-mortem brain. Results: We did not observe any differences in Oct-6 expression between any of the groups under study. Oct-6 mRNA and protein was identically expressed in the hippocampal and cortical regions of most specimens in all groups, including controls. Conclusions: Oct-6 is, therefore, unlikely to be a specific marker for any psychological disorder; rather its expression in controls suggests that it is normally expressed in most adult brains. © 2005 Ubhi and Price, licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Ubhi, K., & Price, J. (2005). Expression of POU-Domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression. BMC Psychiatry, 5. https://doi.org/10.1186/1471-244X-5-38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free